AddLife AB (publ) (ALIF-B.ST)
SEK 153.3
(-0.45%)
SEK 153.3
(-0.45%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.28 Billion SEK | -5.4% |
| 2022 | 5.59 Billion SEK | 36.3% |
| 2021 | 4.1 Billion SEK | 409.07% |
| 2020 | 805.8 Million SEK | -10.1% |
| 2019 | 896.3 Million SEK | 6.0% |
| 2018 | 845.6 Million SEK | 58.74% |
| 2017 | 532.7 Million SEK | 66.05% |
| 2016 | 320.8 Million SEK | -34.02% |
| 2015 | 486.2 Million SEK | 1630.25% |
| 2014 | 28.1 Million SEK | -12.46% |
| 2013 | 32.1 Million SEK | 11.46% |
| 2012 | 28.8 Million SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.83 Billion SEK | -12.71% |
| 2024 Q3 | 5.43 Billion SEK | 12.5% |
| 2024 Q1 | 5.53 Billion SEK | 4.69% |
| 2023 Q2 | 5.9 Billion SEK | 6.46% |
| 2023 Q3 | 5.65 Billion SEK | -4.27% |
| 2023 FY | 5.28 Billion SEK | -5.4% |
| 2023 Q4 | 5.28 Billion SEK | -6.42% |
| 2023 Q1 | 5.54 Billion SEK | -0.8% |
| 2022 Q3 | 5.67 Billion SEK | -0.61% |
| 2022 Q2 | 5.71 Billion SEK | 8.74% |
| 2022 FY | 5.59 Billion SEK | 36.3% |
| 2022 Q1 | 5.25 Billion SEK | 28.01% |
| 2022 Q4 | 5.59 Billion SEK | -1.48% |
| 2021 Q3 | 2.17 Billion SEK | -47.23% |
| 2021 Q1 | 800 Million SEK | -0.72% |
| 2021 Q2 | 4.12 Billion SEK | 416.13% |
| 2021 FY | 4.1 Billion SEK | 409.07% |
| 2021 Q4 | 4.1 Billion SEK | 88.26% |
| 2020 Q2 | 911 Million SEK | -15.88% |
| 2020 FY | 805.8 Million SEK | -10.1% |
| 2020 Q4 | 805.8 Million SEK | 2.78% |
| 2020 Q3 | 784 Million SEK | -13.94% |
| 2020 Q1 | 1.08 Billion SEK | 20.83% |
| 2019 Q3 | 953 Million SEK | 16.93% |
| 2019 Q4 | 896.3 Million SEK | -5.95% |
| 2019 FY | 896.3 Million SEK | 6.0% |
| 2019 Q1 | 592 Million SEK | -29.99% |
| 2019 Q2 | 815 Million SEK | 37.67% |
| 2018 Q1 | 518 Million SEK | -2.76% |
| 2018 Q3 | 626 Million SEK | 16.14% |
| 2018 FY | 845.6 Million SEK | 58.74% |
| 2018 Q4 | 845.6 Million SEK | 35.08% |
| 2018 Q2 | 539 Million SEK | 4.05% |
| 2017 Q2 | 567 Million SEK | 1.43% |
| 2017 Q1 | 559 Million SEK | 74.25% |
| 2017 FY | 532.7 Million SEK | 66.05% |
| 2017 Q4 | 532.7 Million SEK | -14.49% |
| 2017 Q3 | 623 Million SEK | 9.88% |
| 2016 Q4 | 320.8 Million SEK | -41.77% |
| 2016 Q3 | 550.9 Million SEK | -1.34% |
| 2016 Q1 | 486.2 Million SEK | -51.18% |
| 2016 Q2 | 558.4 Million SEK | 14.85% |
| 2016 FY | 320.8 Million SEK | -34.02% |
| 2015 Q4 | 995.9 Million SEK | 0.0% |
| 2015 FY | 486.2 Million SEK | 1630.25% |
| 2015 Q1 | 28.1 Million SEK | 0.0% |
| 2014 FY | 28.1 Million SEK | -12.46% |
| 2013 FY | 32.1 Million SEK | 11.46% |
| 2012 FY | 28.8 Million SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Biotage AB (publ) | 150 Million SEK | -3426.0% |
| Bonesupport Holding AB (publ) | 17.48 Million SEK | -30150.515% |
| Doxa AB (publ) | 9.7 Million SEK | -54425.773% |
| Elekta AB (publ) | 7.24 Billion SEK | 27.028% |
| iZafe Group AB (publ) | 3.17 Million SEK | -166482.677% |
| Ortivus AB (publ) | 5.48 Million SEK | -96396.99% |
| Ortivus AB (publ) | 5.48 Million SEK | -96396.99% |
| Q-linea AB (publ) | 20.56 Million SEK | -25618.454% |
| S2Medical AB (publ) | - SEK | -Infinity% |
| Synsam AB (publ) | 3.25 Billion SEK | -62.488% |